2024 exceptional surveillance of Venous thromboembolism in over 16s (NICE guideline NG89)
September 2024: We have checked the evidence we will not update the guideline. A lack of evidence about VTE risk from HRT in surgical populations means that NICE currently cannot safely recommend that it is safe to continue transdermal HRT for everyone prior to surgery and perioperatively.
This page was last updated: